AEM-18

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAEM-18
Drug Alias NameApo-E peptide mimetic (University of Alabama at Birmingham/LipimetiX)AEM-18
ClassificationSmall molecules > PeptidomimeticBiologics
Mechanisms of ActionApolipoprotein E agonists
TargetsApolipoprotein E
Therapy Area/IndicationsHypercholesterolemiaHyperlipoproteinemia Type II
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama At Birmingham
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipimetixLipimetix Development Llc
Active IndicationsN/A
Inactive IndicationsHypercholesterolemiaHyperlipoproteinemia Type II

Other Information

ATC CodeN/A
Related LinksN/A